Talk 1 · Display of Biologics
Tuesday, 17 November · 10:00 - 10:30 · Display of Biologics track
Accelerating multispecific antibody discovery & development with the B-Body® Platform
Colby Souders, Chief Scientific Officer, Twist Bioscience
Discover the B-Body® platform, the high-performance solution for accelerating multispecific antibody development. Achieve CMC-ready bispecifics in just four weeks with the B-Body Express™ platform. Our proprietary design eliminates light chain mispairing, delivers exceptional yields up to 11 g/L, and ensures low manufacturing risk using standard mAb purification. Screen in the final therapeutic format, including Fc mutations and ADC compatibility, and mitigate risk across all development stages.